Prostate-specific antigen response rate of sequential chemotherapy in castration-resistant prostate cancer: the results of real life practice

PURPOSE: Prostate-specific antigen (PSA) response rate (>50% PSA decline in pretreatment PSA following chemotherapy) carries a significant survival advantage in castration-resistant prostate cancer (CRPC). We compared PSA response rates in first-, second- and third-line chemotherapy after failure...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Song, Geehyun, Lee, Chunwoo, You, Dalsan, Jeong, In Gab, Hong, Jun Hyuk, Ahn, Hanjong, Kim, Choung-Soo
Format: Artigo
Jezik:Inglês
Izdano: Asian Pacific Prostate Society (APPS) 2013
Teme:
Original Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3814118/
https://ncbi.nlm.nih.gov/pubmed/24223414
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12954/PI.13024
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki